These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35847514)

  • 1. Enterovirus A71 antivirals: Past, present, and future.
    Wang J; Hu Y; Zheng M
    Acta Pharm Sin B; 2022 Apr; 12(4):1542-1566. PubMed ID: 35847514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus D68 Antivirals: Past, Present, and Future.
    Hu Y; Musharrafieh R; Zheng M; Wang J
    ACS Infect Dis; 2020 Jul; 6(7):1572-1586. PubMed ID: 32352280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.
    Hu Y; Kitamura N; Musharrafieh R; Wang J
    J Med Chem; 2021 Jun; 64(12):8755-8774. PubMed ID: 34085827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
    Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study.
    Messacar K; Spence-Davizon E; Osborne C; Press C; Schreiner TL; Martin J; Messer R; Maloney J; Burakoff A; Barnes M; Rogers S; Lopez AS; Routh J; Gerber SI; Oberste MS; Nix WA; Abzug MJ; Tyler KL; Herlihy R; Dominguez SR
    Lancet Infect Dis; 2020 Feb; 20(2):230-239. PubMed ID: 31859216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World.
    Gonzalez G; Carr MJ; Kobayashi M; Hanaoka N; Fujimoto T
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress and challenges in drug development to fight hand, foot and mouth disease.
    Lim ZQ; Ng QY; Ng JWQ; Mahendran V; Alonso S
    Expert Opin Drug Discov; 2020 Mar; 15(3):359-371. PubMed ID: 31470744
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
    Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines.
    Apostol LN; Shimizu H; Suzuki A; Umami RN; Jiao MMA; Tandoc A; Saito M; Lupisan S; Oshitani H
    BMC Infect Dis; 2019 May; 19(1):370. PubMed ID: 31046684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into innate and adaptive immune responses in vaccine development against EV-A71.
    Lim HX; Poh CL
    Ther Adv Vaccines Immunother; 2019; 7():2515135519888998. PubMed ID: 31799495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
    Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
    Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of silymarin in comparison with baicalein against EV-A71.
    Lalani SS; Anasir MI; Poh CL
    BMC Complement Med Ther; 2020 Mar; 20(1):97. PubMed ID: 32293397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in anti-EV-A71 drug development research.
    Wang S; Pang Z; Fan H; Tong Y
    J Adv Res; 2024 Feb; 56():137-156. PubMed ID: 37001813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirals and vaccines for Enterovirus A71.
    Lin JY; Kung YA; Shih SR
    J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
    Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
    J Virol; 2021 May; 95(12):. PubMed ID: 33789997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative.
    Ibba R; Carta A; Madeddu S; Caria P; Serreli G; Piras S; Sestito S; Loddo R; Sanna G
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33406781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.